Gadolinium retention in the body: what we know and what we can do

Gadolinium-based contrast agents (GBCA), widely used in Magnetic Resonance Imaging (MRI) for almost 30 years, were recently shown to be deposited in the brain and to induce persistent T1 shortening in deep gray matter structures in subjects with normal renal function. The aim of the present study is...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Radiologia medica Ročník 122; číslo 8; s. 589 - 600
Hlavní autoři:	Tedeschi, Enrico, Caranci, Ferdinando, Giordano, Flavio, Angelini, Valentina, Cocozza, Sirio, Brunetti, Arturo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Milan Springer Milan 01.08.2017 Springer Nature B.V
Témata:	Animals Brain Brain - drug effects Brain - metabolism Contrast agents Contrast Media Contrast Media - adverse effects Contrast Media - metabolism Diagnostic Radiology Gadolinium Gadolinium - adverse effects Gadolinium - metabolism Humans Image Enhancement Imaging Interventional Radiology Magnetic Resonance Imaging Medicine Medicine & Public Health Neuroradiology NMR Nuclear magnetic resonance Organs Radiology Renal function Retention Ultrasound Gadolinium retention Gadolinium-based contrast media MRI Toxicity Dentate nucleus
ISSN:	0033-8362, 1826-6983, 1826-6983
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!